Table 1 Participant characteristics.

From: Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up

  Oxytocin Placebo
Number of participants 21 17
Age 24.76 ± 4.85 24.06 ± 5.54
Handedness 5L/16R 2L/15R
IQ
Total IQ 102 ± 13 107 ± 19
VIQ 106 ± 9 111 ± 13
PIQ 105 ± 18 104 ± 22
ADOS-2
Total 7.2 ± 4.3 7.6 ± 3.9
Communication 2.1 ± 1.4 2.2 ± 1.4
Social interaction 5.1 ± 3.4 5.4 ± 3.1
Use of psychostimulant medication 5 2
Comorbidity 7 2
  1. Data are shown as mean ± standard deviation. Detailed information on medication use and comorbidities is provided in Supplementary Table 1.
  2. L left-handed, R right-handed, IQ intelligence quotient, VIQ verbal IQ, PIQ performance IQ, ADOS autism diagnostic observation schedule.